has sponsored live events, journal education, and internet-based CME activities and has awarded more than 80,000 hours of CME credit.Early View from The Oncologist
- Results of the Survey Conducted Among Caribbean Physicians on a Zoom Meeting Discussing the Article “A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative…
- Providing Supportive and Palliative Care Using Telemedicine for Patients with Advanced Cancer During the COVID‐19 Pandemic in Mexico
- Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines
- Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report
- Multicenter comparison of Molecular Tumor Boards in the Netherlands: definition, composition, methods and targeted therapy recommendations
- Erdheim‐Chester Disease and Langerhans cell histiocytosis: a case of overlap‐syndrome
- Dramatic changes in oncology care pathways during the COVID‐19 pandemic: The French ONCOCARE‐COV study
- A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26‐104/RFASE in Patients with Advanced Solid Malignancies
- “Often Relatives are the Key […]” –Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life
- Correlation Between Bevacizumab Exposure and Survival Does Not Necessarily Imply Causality